• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Celularity Inc. - Class A Common Stock (NQ:CELU)

    0.9570 +0.0227 (+2.43%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Celularity Inc. - Class A Common Stock

    News headline image
    Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
    Company presents results from in vivo studies of PT-CD16VS, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells, in combination with various monoclonal... 
    From Celularity Inc.
    Via GlobeNewswire
    News headline image
    Celularity Inc. to Host Investor and Analyst Research & Development Day
    Event Will Be Hosted On-site and Aired Virtually Highlighting Research, Clinical and Commercial Progress 
    From Celularity Inc.
    Via GlobeNewswire
    News headline image
    Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
    From Celularity Inc.
    Via GlobeNewswire
    News headline image
    Celularity and CH Trading Group Announce Product Distribution Agreement with Tamer Group to be the Exclusive Distributor for the Kingdom of Saudi Arabia
    From Celularity Inc.
    Via Business Wire
    News headline image
    Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East
    From Celularity Inc.
    Via Business Wire
    CIRCLE H INTERNATIONAL (Ⓗ®™) SHARIA ADVISORY COUNCIL ISSUES UNPRECEDENTED FATWA FOR CONDITIONAL PERMITTED USE OF STEM CELLS, EXOSOMES, AND BIOMATERIALS IN RESEARCH, CLINICAL TRIALS AND TREATMENT
    New York, New York, United States - 12-20-2022 (PR Distribution™) - 
    Via PR Distribution
    Topics Religion
    News headline image
    Celularity Announces Halal Certification of its Advanced Cellular Therapeutics, Biomaterial Products and Business Model
    From Celularity Inc.
    Via Business Wire
    News headline image
    Celularity CEO Robert J. Hariri, M.D., Ph.D., Addresses FII Conference on “The Science and Technology for Extending Healthy Human Lifespan”
    From Celularity, Inc.
    Via Business Wire
    How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
    Via FinancialNewsMedia
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.